Strategies in human in-vitro maturation and their clinical outcome (Q36159118)

12 August 2017

1 reference

title

Strategies in human in-vitro maturation and their clinical outcome (English)

1 reference

12 August 2017

Anne Lis Mikkelsen

1

1 reference

12 August 2017

1 May 2005

1 reference

Reproductive BioMedicine Online

12 August 2017

1 reference

12 August 2017

10

1 reference

12 August 2017

5

1 reference

12 August 2017

593-599

1 reference

Enhancement of primate oocyte maturation and fertilization in vitro by inhibin A and activin A.

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Effect of recombinant human gonadotrophins on human, bovine and murine oocyte meiosis, fertilization and embryonic development in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

The role of intra-ovarian interactions in the regulation of follicle dominance

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Blastocyst development and birth after in-vitro maturation of human primary oocytes, intracytoplasmic sperm injection and assisted hatching.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Production of embryos from in vitro-matured primary human oocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Maturation in vitro of immature human oocytes for clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

In-vitro maturation of immature oocytes for infertile women with PCOS.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

In-vitro maturation of human oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Maturation in vitro of human oocytes from unstimulated cycles: selection of the optimal day for ovum retrieval based on follicular size

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

In vitro follicle growth: achievements in mammalian species

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Follicle stimulating hormone effects on immature human oocytes: in vitro maturation and hormone production

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Maturation in vitro of human ovarian oöcytes

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Maturation in vitro of Mouse, Sheep, Cow, Pig, Rhesus Monkey and Human Ovarian Oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Early Stages of Fertilization in vitro of Human Oocytes Matured in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Development in vitro of mouse oocytes from primordial follicles.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Relationship between the developmental programs controlling nuclear and cytoplasmic maturation of mouse oocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Factors affecting the developmental competence of mouse oocytes grown in vitro: follicle-stimulating hormone and insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

In-vitro maturation of human germinal vesicle stage oocytes: role of cumulus cells and epidermal growth factor in the culture medium.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Extracellular matrix improves survival of both stored and fresh human primordial and primary ovarian follicles in long-term culture

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Recombinant LH is equally effective as recombinant hCG in promoting oocyte maturation in a clinical in-vitro maturation programme: a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

In vitro maturation and fertilization of immature oocytes: a comparative study of fertilization techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Successful in vitro maturation of human oocytes not exposed to human chorionic gonadotropin during ovulation induction, resulting in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Regulation of follicle development and novel approaches to ovarian stimulation for IVF.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Influence of the dominant follicle on in-vitro maturation of human oocytes: a prospective non-randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

In-vitro maturation of human oocytes from regularly menstruating women may be successful without follicle stimulating hormone priming.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Impact of oestradiol and inhibin A concentrations on pregnancy rate in in-vitro oocyte maturation.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Basal concentrations of oestradiol may predict the outcome of in-vitro maturation in regularly menstruating women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Pregnancy and birth after intracytoplasmic sperm injection of in vitro matured germinal-vesicle stage oocytes: case report.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Growth patterns of nondominant ovarian follicles during the normal menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

THE COMPARATIVE BEHAVIOR OF MAMMALIAN EGGS IN VIVO AND IN VITRO : I. THE ACTIVATION OF OVARIAN EGGS

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Gonadotropins augment maturation and fertilization of human immature oocytes cultured in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Donor eggs: their application in modern reproductive technologies

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Unstimulated immature oocyte retrieval: early versus midfollicular endometrial priming.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Dynamics of human follicular growth and in-vitro oocyte maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Development of human oocytes matured in vitro for 28 or 36 hours.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Oocyte in-vitro maturation and follicle culture: current clinical achievements and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery, maturation and fertilization of immature human oocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Immature oocyte retrieval: lessons from unstimulated IVF cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients*

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

1 reference

7 January 2021

Maturation of human oocytes in vitro and their developmental competence.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Primate and bovine immature oocytes and follicles as sources of fertilizable oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Effects of ovarian source, patient age, and menstrual cycle phase on in vitro maturation of immature human oocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961666-5

7 January 2021

10.1016/S1472-6483(10)61666-5

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15949216